Increased miR-424-5p expression in peripheral blood mononuclear cells from patients with pemphigus

Wang,Menglei; Liang,Liuping; Li,Li; Han,Kai; Li,Qian; Peng,Yusheng; Peng,Xuebiao; Zeng,Kang

doi:10.3892/mmr.2017.6422

Increased miR-424-5p expression in peripheral blood mononuclear cells from patients with pemphigus

Authors:
- Menglei Wang
- Liuping Liang
- Li Li
- Kai Han
- Qian Li
- Yusheng Peng
- Xuebiao Peng
- Kang Zeng
View Affiliations

Affiliations: Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China
Published online on: April 3, 2017 https://doi.org/10.3892/mmr.2017.6422
Pages: 3479-3484
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pemphigus is an autoimmune disease that causes blisters and erosions in the skin and mucous membranes. The development of pemphigus is associated with the imbalance of T‑cell and humoral responses. MicroRNAs (miRNAs) can regulate many cell functions. However, whether miRNA expression is altered in peripheral blood mononuclear cells (PBMCs) during the pathogenesis of pemphigus has not been clarified. The aim of the present study was to examine the miRNA expression profiles of PBMCs from patients with pemphigus. The expression profiles of miRNAs in PBMCs from patients with active pemphigus (n=3) and healthy subjects (n=3) were analyzed by microarray. The relative levels of miR-424-5p expression in PBMCs from 9 patients and controls were validated by RT-qPCR. The functional and biological processes of the differentially expressed miRNAs were analyzed by bioinformatics. There were 124 differentially expressed miRNAs in PBMCs from the patients with pemphigus, compared with healthy controls, including 71 that were upregulated (P<0.05, fold change >2), and 53 that were downregulated (P<0.05, fold change <0.5). miR-424-5p was highly expressed in patients with pemphigus. Bioinformatics analysis indicated that the genes targeted by miR-424-5p were involved in intracellular signaling cascades, phosphate metabolism and regulation of kinase activity. The predicted target genes were associated with the T-cell receptor and mitogen-activated protein kinase signaling pathways as well as others. In conclusion, the results have demonstrated the miRNA expression profile, and verified that miR-424-5p was upregulated in PBMCs from patients with pemphigus. The biological function and potential pathways of miR-424-5p in pemphigus were predicted. Thus, miR-424-5p may contribute to the pathogenesis of pemphigus.

View Figures

View References

1	Rizzo C, Fotino M, Zhang Y, Chow S, Spizuoco A and Sinha AA: Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active disease. Clin Exp Dermatol. 30:535–540. 2005. View Article : Google Scholar : PubMed/NCBI
2	Sugiyama H, Matsue H, Nagasaka A, Nakamura Y, Tsukamoto K, Shibagaki N, Kawamura T, Kitamura R, Ando N and Shimada S: CD4⁺CD25^high regulatory T cells are markedly decreased in blood of patients with pemphigus vulgaris. Dermatology. 214:210–220. 2007. View Article : Google Scholar : PubMed/NCBI
3	von Bubnoff D, Andrès E, Hentges F, Bieber T, Michel T and Zimmer J: Natural killer cells in atopic and autoimmune diseases of the skin. J Allergy Clin Immunol. 125:60–68. 2010. View Article : Google Scholar : PubMed/NCBI
4	Xu RC, Zhu HQ, Li WP, Zhao XQ, Yuan HJ, Zheng J and Pan M: The imbalance of Th17 and regulatory T cells in pemphigus patients. Eur J Dermatol. 23:795–802. 2013.PubMed/NCBI
5	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
6	Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B, Müller P, et al: Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature. 408:86–89. 2000. View Article : Google Scholar : PubMed/NCBI
7	Chen CZ: MicroRNAs as oncogenes and tumor suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
8	Xiao C and Rajewsky K: MicroRNA control in the immune system: basic principles. Cell. 136:26–36. 2009. View Article : Google Scholar : PubMed/NCBI
9	Simpson LJ and Ansel KM: MicroRNA regulation of lymphocyte tolerance and autoimmunity. J Clin Invest. 125:2242–2249. 2015. View Article : Google Scholar : PubMed/NCBI
10	Heegaard NH, Carlsen AL, Skovgaard K and Heegaard PM: Circulating extracellular microRNA in systemic autoimmunity. EXS. 106:171–195. 2015.PubMed/NCBI
11	Amagai M, Tanikawa A, Shimizu T, Hashimoto T, Ikeda S, Kurosawa M, Niizeki H, Aoyama Y, Iwatsuki K and Kitajima Y: Committee for Guidelines for the Management of Pemphigus Disease: Japanese guidelines for the management of pemphigus. J Dermatol. 41:471–486. 2014. View Article : Google Scholar : PubMed/NCBI
12	Noble WS: How does multiple testing correction work? Nat Biotechnol. 27:1135–1137. 2009. View Article : Google Scholar : PubMed/NCBI
13	Grassmann F, Schoenberger PG, Brandl C, Schick T, Hasler D, Meister G, Fleckenstein M, Lindner M, Helbig H, Fauser S, et al: A circulating microRNA profile is associated with late-stage neovascular age-related macular degeneration. PLoS One. 9:e1074612014. View Article : Google Scholar : PubMed/NCBI
14	Braza-Boïls A, Salloum-Asfar S, Marí-Alexandre J, Arroyo AB, González-Conejero R, Barceló-Molina M, García-Oms J, Vicente V, Estellés A, Gilabert-Estellés J, et al: Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis. Hum Reprod. 30:2292–2302. 2015. View Article : Google Scholar : PubMed/NCBI
15	Wu K, Hu G, He X, Zhou P, Li J, He B and Sun W: MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer. Pathol Oncol Res. 19:739–748. 2013. View Article : Google Scholar : PubMed/NCBI
16	Zhang Y, Li T, Guo P, Kang J, Wei Q, Jia X, Zhao W, Huai W, Qiu Y, Sun L, et al: miR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression. Sci Rep. 4:62482014. View Article : Google Scholar : PubMed/NCBI
17	Meng QL, Liu F, Yang XY, Liu XM, Zhang X, Zhang C and Zhang ZD: Identification of latent tuberculosis infection-related microRNAs in human U937 macrophages expressing Mycobacterium tuberculosis Hsp16.3. BMC Microbiol. 14:372014. View Article : Google Scholar : PubMed/NCBI
18	Jinnin M: Recent progress in studies of miRNA and skin diseases. J Dermatol. 42:551–558. 2015. View Article : Google Scholar : PubMed/NCBI
19	Forrest AR, Kanamori-Katayama M, Tomaru Y, Lassmann T, Ninomiya N, Takahashi Y, de Hoon MJ, Kubosaki A, Kaiho A, Suzuki M, et al: Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia. 24:460–466. 2010. View Article : Google Scholar : PubMed/NCBI
20	Li X, Ishii N, Ohata C, Furumura M and Hashimoto T: Signalling pathways in pemphigus vulgaris. Exp Dermatol. 23:155–156. 2014. View Article : Google Scholar : PubMed/NCBI
21	Coulthard LR, White DE, Jones DL, McDermott MF and Burchill SA: p38(MAPK): stress responses from molecular mechanisms to therapeutics. Trends Mol Med. 15:369–379. 2009. View Article : Google Scholar : PubMed/NCBI
22	Chernyavsky AI, Arredondo J, Kitajima Y, Sato-Nagai M and Grando SA: Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. J Biol Chem. 282:13804–13812. 2007. View Article : Google Scholar : PubMed/NCBI
23	Berkowitz P, Hu P, Liu Z, Diaz LA, Enghild JJ, Chua MP and Rubenstein DS: Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J Biol Chem. 280:23778–23784. 2005. View Article : Google Scholar : PubMed/NCBI
24	Lee HE, Berkowitz P, Jolly PS, Diaz LA, Chua MP and Rubenstein DS: Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis. J Biol Chem. 284:12524–12532. 2009. View Article : Google Scholar : PubMed/NCBI
25	Berkowitz P, Hu P, Warren S, Liu Z, Diaz LA and Rubenstein DS: p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc Natl Acad Sci USA. 103:pp. 12855–12860. 2006; View Article : Google Scholar : PubMed/NCBI
26	Berkowitz P, Diaz LA, Hall RP and Rubenstein DS: Induction of p38MAPK and HSP27 phosphorylation in pemphigus patient skin. J Invest Dermatol. 128:738–740. 2008. View Article : Google Scholar : PubMed/NCBI
27	Meunier I, Lenaers G, Bocquet B, Baudoin C, Piro-Megy C, Cubizolle A, Quilès M, Jean-Charles A, Cohen SY, Merle H, et al: A dominant mutation in MAPKAPK3, an actor of p38 signaling pathway, causes a new retinal dystrophy involving Bruch's membrane and retinal pigment epithelium. Hum Mol Genet. 25:916–926. 2016. View Article : Google Scholar : PubMed/NCBI
28	Lemaire M, Ducommun B and Nebreda AR: UV-induced downregulation of the CDC25B protein in human cells. FEBS Lett. 584:1199–1204. 2010. View Article : Google Scholar : PubMed/NCBI
29	Lemaire M, Froment C, Boutros R, Mondesert O, Nebreda AR, Monsarrat B and Ducommun B: CDC25B phosphorylation by p38 and MK-2. Cell Cycle. 5:1649–1653. 2006. View Article : Google Scholar : PubMed/NCBI
30	Song GQ and Zhao Y: MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells' growth and migration. Tumour Biol. 36:5001–5009. 2015. View Article : Google Scholar : PubMed/NCBI
31	Kar S, Wang M, Ham SW and Carr BI: Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK. Biochem Pharmacol. 72:1217–1227. 2006. View Article : Google Scholar : PubMed/NCBI
32	Wang M, Zhu XY, Wang L and Lin Y: Expression and signi-ficance of CDC25B, PED/PEA-15 in esophageal carcinoma. Cancer Biother Radiopharm. 30:139–145. 2015. View Article : Google Scholar : PubMed/NCBI